cheryl
Administrator
Staff member
A look at the latest food allergy research - Stanford
When Stanford professor Russ Altman, MD, PhD, was in his 20s, he began to suspect he had developed an allergy to shellfish. After a seafood meal, his face was red, he was wheezing, his nose ran and his eyes watered.
Altman, who had happy childhood memories of his grandfather hosting lobster feasts for his family, was devastated when allergy testing confirmed his suspicions: He was particularly allergic to shrimp, crab and lobster. His doctors gave him strict instructions to avoid all three, which he did for decades. He also joked to friends and family that, once he was old and on the brink of death, he'd eat a big plate of lobster for his last meal.
But then something changed: Altman talked with Stanford food allergy expert Kari Nadeau, MD, PhD, who said she could help. Nadeau suggested that Altman undergo oral immunotherapy, a food allergy treatment that she and her team at the Sean N. Parker Center for Allergy & Asthma Research have studied extensively in several clinical trials.
When Stanford professor Russ Altman, MD, PhD, was in his 20s, he began to suspect he had developed an allergy to shellfish. After a seafood meal, his face was red, he was wheezing, his nose ran and his eyes watered.
Altman, who had happy childhood memories of his grandfather hosting lobster feasts for his family, was devastated when allergy testing confirmed his suspicions: He was particularly allergic to shrimp, crab and lobster. His doctors gave him strict instructions to avoid all three, which he did for decades. He also joked to friends and family that, once he was old and on the brink of death, he'd eat a big plate of lobster for his last meal.
But then something changed: Altman talked with Stanford food allergy expert Kari Nadeau, MD, PhD, who said she could help. Nadeau suggested that Altman undergo oral immunotherapy, a food allergy treatment that she and her team at the Sean N. Parker Center for Allergy & Asthma Research have studied extensively in several clinical trials.